IL130877A0 - Quinoxalines in a triple combination with protease inhibitors and reverse transcriptase inhibitors as medicaments for the treatment of aids - Google Patents

Quinoxalines in a triple combination with protease inhibitors and reverse transcriptase inhibitors as medicaments for the treatment of aids

Info

Publication number
IL130877A0
IL130877A0 IL13087798A IL13087798A IL130877A0 IL 130877 A0 IL130877 A0 IL 130877A0 IL 13087798 A IL13087798 A IL 13087798A IL 13087798 A IL13087798 A IL 13087798A IL 130877 A0 IL130877 A0 IL 130877A0
Authority
IL
Israel
Prior art keywords
quinoxalines
medicaments
aids
inhibitors
treatment
Prior art date
Application number
IL13087798A
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of IL130877A0 publication Critical patent/IL130877A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
IL13087798A 1997-01-29 1998-01-15 Quinoxalines in a triple combination with protease inhibitors and reverse transcriptase inhibitors as medicaments for the treatment of aids IL130877A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19703131A DE19703131A1 (en) 1997-01-29 1997-01-29 Use of quinoxaline in a combination of three with protease inhibitors and reverse transcriptase inhibitors as medicaments for the treatment of AIDS and / or HIV infections
PCT/EP1998/000197 WO1998032442A1 (en) 1997-01-29 1998-01-15 Quinoxaline in triple combination with protease inhibitors and reverse transcriptase inhibitors as medicines for treating aids

Publications (1)

Publication Number Publication Date
IL130877A0 true IL130877A0 (en) 2001-01-28

Family

ID=7818634

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13087798A IL130877A0 (en) 1997-01-29 1998-01-15 Quinoxalines in a triple combination with protease inhibitors and reverse transcriptase inhibitors as medicaments for the treatment of aids

Country Status (16)

Country Link
EP (1) EP0977570A1 (en)
JP (1) JP2001511124A (en)
KR (1) KR20000070543A (en)
CN (1) CN1251525A (en)
AR (1) AR011094A1 (en)
AU (1) AU6094098A (en)
BR (1) BR9807523A (en)
CA (1) CA2278773A1 (en)
DE (1) DE19703131A1 (en)
ID (1) ID22414A (en)
IL (1) IL130877A0 (en)
NO (1) NO993670L (en)
PL (1) PL334770A1 (en)
SK (1) SK99899A3 (en)
WO (1) WO1998032442A1 (en)
ZA (1) ZA98679B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4219799A (en) * 1998-05-29 1999-12-13 University Of Florida Combination therapy for treatment of fiv infection
US6875773B1 (en) 1998-05-29 2005-04-05 Ben M. Dunn Combination therapy for treatment of FIV infection
GB9821000D0 (en) * 1998-09-28 1998-11-18 Glaxo Group Ltd Antiviral combinations
WO2000018384A2 (en) * 1998-09-28 2000-04-06 Glaxo Group Limited Antiviral combinations comprising (s)-2-ethyl-7-fluoro-3-oxo-3,4-dihydro-2h-quinoxaline-1-carboxylic acid isopropyl ester and amprenavir
GB9911887D0 (en) * 1999-05-21 1999-07-21 Glaxo Group Ltd Methods and medicaments for post exposure prophylaxis of an hiv infection
SE9902987D0 (en) 1999-08-24 1999-08-24 Astra Pharma Prod Novel compounds
CO5300399A1 (en) 2000-02-25 2003-07-31 Astrazeneca Ab HETEROCICLIOCS CONTAINING NITROGEN, PROCESS FOR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
AR028948A1 (en) 2000-06-20 2003-05-28 Astrazeneca Ab NEW COMPOUNDS
US7005439B2 (en) 2000-06-20 2006-02-28 Astrazeneca Ab Compounds
GB0104050D0 (en) 2001-02-19 2001-04-04 Astrazeneca Ab Chemical compounds
AR035230A1 (en) 2001-03-19 2004-05-05 Astrazeneca Ab BENCIMIDAZOL COMPOUNDS, PROCESS FOR PREPARATION, PHARMACEUTICAL COMPOSITION, PROCESS FOR THE PREPARATION OF SUCH PHARMACEUTICAL COMPOSITION, AND USES OF THESE COMPOUNDS FOR THE PREPARATION OF MEDICINES
GB0107228D0 (en) 2001-03-22 2001-05-16 Astrazeneca Ab Chemical compounds
SE0101038D0 (en) 2001-03-23 2001-03-23 Astrazeneca Ab Novel compounds
SE0103818D0 (en) 2001-11-15 2001-11-15 Astrazeneca Ab Chemical compounds
SE0301369D0 (en) 2003-05-09 2003-05-09 Astrazeneca Ab Chemical compounds
US7351709B2 (en) 2004-06-09 2008-04-01 Wyeth Estrogen receptor ligands
TW200738634A (en) 2005-08-02 2007-10-16 Astrazeneca Ab New salt
WO2007068380A1 (en) * 2005-12-15 2007-06-21 Bayer Healthcare Ag Diaryl urea for treating virus infections

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT509398E (en) * 1991-04-15 2002-02-28 Aventis Pharma Gmbh QUINOXALINES PROCESS FOR THEIR PREPARATION AND ITS UTILIZATION
DE4342024A1 (en) * 1993-12-09 1995-06-14 Hoechst Ag Combination preparations containing a quinoxaline and a nucleoside
DE19506742A1 (en) * 1995-02-27 1996-08-29 Bayer Ag Use of quinoxalines in combination with protease inhibitors as medicaments for the treatment of AIDS and / or HIV infections

Also Published As

Publication number Publication date
KR20000070543A (en) 2000-11-25
SK99899A3 (en) 2000-03-13
WO1998032442A1 (en) 1998-07-30
NO993670D0 (en) 1999-07-28
JP2001511124A (en) 2001-08-07
ZA98679B (en) 1998-08-05
PL334770A1 (en) 2000-03-13
BR9807523A (en) 2000-03-21
NO993670L (en) 1999-09-10
DE19703131A1 (en) 1998-07-30
ID22414A (en) 1999-10-14
CN1251525A (en) 2000-04-26
CA2278773A1 (en) 1998-07-30
AU6094098A (en) 1998-08-18
AR011094A1 (en) 2000-08-02
EP0977570A1 (en) 2000-02-09

Similar Documents

Publication Publication Date Title
IL130877A0 (en) Quinoxalines in a triple combination with protease inhibitors and reverse transcriptase inhibitors as medicaments for the treatment of aids
HUP0203367A3 (en) Benzylidine-thiazolidinediones and analogues and their use in the treatment of diabetes
AU2001293553A1 (en) Phosphatidylserine-carrying apoptosis-mimicking bodies and the use thereof in medical treatment
EP1033910A4 (en) Dipeptide apoptosis inhibitors and the use thereof
AU6897198A (en) Use of chondroitinase in the manufacture of a medicament in the treatment and prevention of mucoid secretions
AU5127098A (en) Use of a combination of penciclovir and alpha-interferon in the manufacture of a medicament for the treatment of hepatitis
IL138732A0 (en) The use of polyamines in the treatment of dermatological symptoms
HK1020259A1 (en) Composition for use in the treatment and prevention of hyperuricemia.
HK1020564A1 (en) Benzamidine derivatives and the use thereof as medicaments with ltb4-antagonistic effect
IL148974A0 (en) Use of dipyridamole or mopidamol in the manufacture of a medicament for the treatment and prevention of fibrin-dependent microcirculation disorders
AU5618501A (en) Dihydropyrimidines and the use thereof as medicaments for the treatment of hepatitis
ZA961516B (en) Use of quinoxalines in combination with protease inhibitors as medicament for treatis aids and/or hiv infections
ZA975288B (en) The use of TCET in the prophylaxis and treatment of allergies.
GB2383537B (en) Use of a compound in providing refreshedness on waking and a method for the treatment of drowsiness therewith
AU2002313364A1 (en) Use of a compound in providing refreshedness on waking and a method for the treatment of drowsiness therewith
AU7688998A (en) Use of metalloproteinase inhibitors in the treatment and prevention of pulmonaryemphysema
AU1430099A (en) Use of galanthamine and galanthamine derivatives in the case of acute functionalbrain damage
IL141056A0 (en) Protease inhibitors for use in the treatment of psoriasis
HUP0001976A3 (en) Antiviral protease inhibitors and pharmaceutical compositions
AU9341398A (en) Protease precursors that can be autocatalytically activated and their use
AU4923100A (en) Use of the combination of amino acids having an aliphatic side chain and having a basic side chain in topical hair treatment
AU2001260291A1 (en) Combination of cerivastatin with ace inhibitors and the use thereof in medicaments
GB9613488D0 (en) HIV protease inhibitors useful in the treatment of aids
IL146940A0 (en) Novel calpains and their use
AU2002237251A1 (en) A pharmaceutical composition containing benzopyrano-oxopyrimidotetrahydrothiazine and its use in the treatment of hiv